All of GBP's principals have unrivalled experience in commercialising life science technologies, with detailed knowledge and understanding of the process of generating and building commercial value from research outputs. This experience enables GBP to recognise and shape opportunities for investment.
GBP only invests in life sciences, and typically only in sub-sectors of the life sciences its principals know well (see Investments page). This focus means the syndicate may invest in technologies that general funds would be less likely to consider because they lack the expertise to assess the detailed science of many propositions. GBP's focus leads to it being asked to provide technological due diligence for other investment groups.
GBP are specialists in their technical field, and have been for many years. They are well known and are networked internationally. Their experience gives them unrivalled access to the major, international players in the supply chain. This converts to real opportunities to shape the value proposition for potential purchasers or licensees, and to realise value from GBP's investments.